Comparison of Helicobacter pylori infection frequency in the cardia and distal esophageal cancer patients with healthy individuals
DOI:
https://doi.org/10.18203/2349-3933.ijam20161103Keywords:
Helicobacter pylori, Cardia cancer, Esophageal cancer, ArdabilAbstract
Background: Helicobacter pylori is a bacterium that detaches from human beings all over the world, i.e., human being is the largest reservoir of this organism. The aim of this study was to investigate the prevalence of infection among patients with esophageal and gastric cardia cancers and healthy people.
Methods: This case-control study was done on 144 persons who were divided into two groups (72 persons in each group). The control group included cases with normal endoscopy and the second group involved patients with gastric cardiac and distal esophageal cancer. Patients were sent to a lab to take stool samples. After receiving the lab reports, information was entered in the checklists and then was analyzed via statistical methods using SPSS 19.
Results: The percentage of male cases in was 59.7% in case group and 48.6% in control group. The mean age of all patients was 64.2. In the case group 40.3% of patients were smokers and while this percentage was 23.6% in control group. The most common clinical symptom was dyspepsia in 94.4% of the patients. 27.8% of the individuals in the case group and 22.2% of those in control group were with positive gastrointestinal cancer history in family. 45.8% and 54.2% of patients were with cardia and distal esophageal cancer respectively. The incidence of H pylori infection in the case group was 37.5%, which was lower than the control group being 58.3% (p=0.012, OR=0.4, 0.2-0.8).
Conclusions: The results showed that Helicobacter pylori infection may play a protective role in the development of esophageal and cardia cancers.
References
Mandell G, Dolin R, Benntts J. Principles and Practice of Infectious Disease. 5ed. NewYork, Churchill living stone. 2000 : 2285-91.
Braunwald E, Fauci A, Kasper D. Harrison’s principle of internal medicine, 15th ed. USA, Macgrow-Hill, 2001: 960-2.
Goldman L, Bennett J. Cecil textbook of medicine, 21st ed. Philadelphia, Pennsylvania. W.P. Saunders Co, 2000: 671-7.
Gallo A, Cha C. Updates on esophageal and gastric cancers. World J Gastroenterol. 2006;12(20):3237-42.
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10-30.
Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2007;17(1):2-9.
Islami F, Kamangar F. Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysis. Cancer Prev Res. 2008;1(5);42(4):33-8.
Ferlay J, Bray F, Pisani P. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. International Agency for Research on Cancer, Base No. 5. Version 2.0, IARC Press, Lyon, 2004.
Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142-6.
Lagergren J, Bergstrom R, Lindgren A. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer. 2000;85:340-6.
Mayne ST, Navarro SA. Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J Nutr. 2002;132:S3467-70.
Lagergren J. Controversies surrounding body mass, reflux, and risk of oesophageal adenocarcinoma. Lancet Oncol. 2006;7:347-9.
Khoshbaten M, Zadimani A, Bonyadi MR, Mohammadzadeh M. Helicobacter pylori infection reduces the risk of esophageal squamous cell carcinoma: a case-control study in Iran. Asian Pac J Cancer Prev. 2011;12(1):149-51.
de Martel C, Llosa AE, Farr SM, Friedman GD, Vogelman JH, Orentreich N. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis. 2005;191(5):761-7.
Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol. 2004;57(1):37-42.
Ye W, Held M, Lagergren J, Engstrand L, Blot WJ. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96(5):388-96.
Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL. An inverse relation between cagA+ strains of helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998;58(4):588-90.
Simán JH, Engstrand L, Berglund G, Forsgren A, Florén CH. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Scand J Gastroenterol. 2007;42(8):933-40.
Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer. 2003;103(6):815-21.
Wu IC, Wu DC, Yu FJ, Wang JY, Kuo CH, Yang SF. Association between Helicobacter pylori seropositivity and digestive tract cancers. World J Gastroenterol. 2009;15(43):5465-71.
Anderson LA, Murphy SJ, Johnston BT, Watson RG. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut. 2008;57(6):734-9.
Whiteman DC, Parmar P, Fahey P. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology. 2010;139(1):73-83.
